1029623-72-0 Usage
Uses
Used in Pharmaceutical Industry:
2,5-Difluorothiobenzamide is used as a building block for the synthesis of various pharmaceutical compounds, contributing to the development of new drugs and therapeutic agents.
Used in Cancer Research:
2,5-Difluorothiobenzamide is used as a potential therapeutic agent in cancer research, being studied for its capacity to treat various types of cancer and other diseases, thereby offering new avenues for medical advancements.
Used in Organic Synthesis:
As an important intermediate in organic synthesis, 2,5-Difluorothiobenzamide is used in research and development for the creation of novel chemical entities and the advancement of chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1029623-72-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,9,6,2 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1029623-72:
(9*1)+(8*0)+(7*2)+(6*9)+(5*6)+(4*2)+(3*3)+(2*7)+(1*2)=140
140 % 10 = 0
So 1029623-72-0 is a valid CAS Registry Number.
1029623-72-0Relevant academic research and scientific papers
TRIAZOLE COMPOUNDS AS KSP INHIBITORS
-
Page/Page column 13; 23-24, (2011/10/31)
The present invention provides triazole compounds of Formula I: as further described herein. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I, and a method of treating a diso
SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS
-
Page/Page column 48, (2008/12/05)
Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof
Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
-
Page/Page column 26, (2010/11/08)
A subject of the invention is a selective process for the preparation of derivatives of benzothiazole-4,7-diones and benzoxazole-4,7-diones monosubstituted in position 5 or in position 6 by an amino group itself optionally substituted. Said derivatives ar
